• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACCRIVA DIAGNOSTICS HEMOCHRON SIGNATURE ELITE INTERNATIONAL; SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACCRIVA DIAGNOSTICS HEMOCHRON SIGNATURE ELITE INTERNATIONAL; SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Back to Search Results
Model Number ELITE-INT
Device Problem Non Reproducible Results (4029)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/09/2018
Event Type  malfunction  
Manufacturer Narrative
This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite international instrument, serial number (b)(4).Accriva diagnostics' complaint number (b)(4) referenced the child case capturing the disposable hemochron jr.Act-lr device (lot number j7jlr194) that was used during the procedure.Method: testing of actual/suspected device.Dhr review showed no ncs, capa, or a relevant history of repair.Results: no device problem found.The instrument was tested to heparin sensitivty procedure qc-188 using 2 lots of act-lr cuvettes and side by side with 3 other control instruments.The device performed within specifications.Conclusion: no problem detected.This mdr serves as the initial and final report for the hemochron signature elite and act-lr microcoagulation system, instrument serial number (b)(4), lot j7jlr194.The complaint was not confirmed.
 
Event Description
Healthcare professional working in a hospital in (b)(6) reported that two hemochron signature elite and act low-range assay systems reported inconsistent act results when the meters were run side-to-side during a pci and stent placement procedure.The patient was receiving intermittent doses of intravenous heparin with a target act range of 300-350 seconds.The same lot number of hemochron jr act-lr cuvettes (j7jlr194) was used on both meters throughout the procedure.One blood sample generated a pair of act results that differed significantly from one another.The act result assayed on the elite named in this complaint ((b)(4)) was 254 seconds, which was lower than the target act.The act result reported on the second elite ((b)(4)) was 321 seconds, which was an expected result.The act result of 321 seconds was used for patient management.No bleeding, thrombosis or other medical complications were reported.Both hemochron signature elite instruments passed electronic qc before the procedure.Act-lr readings with liquid qc (normal and abnormal levels) were within their acceptable ranges when run on both instruments.The distributor asked the customer to return the device for evaluation, however, the customer declined to do so as of (b)(6) 2018, when accriva closed the initial complaint.The complaint case was reopened on (b)(6) 2018 when the customer decided to return the instrument to accriva for evaluation because of recurrent instances of reporting inconsistent act results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOCHRON SIGNATURE ELITE INTERNATIONAL
Type of Device
SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Manufacturer (Section D)
ACCRIVA DIAGNOSTICS
6260 sequence drive
san diego CA 92121
Manufacturer (Section G)
ACCRIVA DIAGNOSTICS
6260 sequence drive
san diego CA 92121
Manufacturer Contact
jon mcdermed
6260 sequence drive
san diego, CA 92121
8582632490
MDR Report Key7993153
MDR Text Key126246717
Report Number2250033-2018-00024
Device Sequence Number1
Product Code JPA
Combination Product (y/n)N
Reporter Country CodeTC
PMA/PMN Number
K050016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Biomedical Engineer
Type of Report Initial
Report Date 09/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberELITE-INT
Device Catalogue NumberELITE-INT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/26/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/20/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Age85 YR
Patient Weight70
-
-